This PBSS workshop (Oct 2, Boston) will showcase the latest tools and case studies for predicting human PK and guiding dose selection across small molecules, biologics, and emerging modalities. Topics include ML-based PK prediction, cross-industry IQ Consortium efforts, PK/PD-informed FIH dose selection, and integrated modeling approaches to support therapeutic index estimation. Attendees will gain practical insights to advance predictive strategies in drug development.
Meet Us There
Request a meeting with us while we’re in town to discuss any upcoming projects or learn more about our approach to OSD drug development and clinical supply manufacturing.
